Silencing of CD90 in vivo by injection of a lentiviral shRNA vector into the inguinal fat pad resulted in decreased ASC proliferation, adipocyte hypertrophy, and glucose intolerance, while body weight was not affected. This evidence concerns the gene THY1 and Glucose intolerance.